GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » E10

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) E10 : €1.53 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Laboratorios Farmaceuticos Rovi's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.292. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.53 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Laboratorios Farmaceuticos Rovi's average E10 Growth Rate was -100.00% per year. During the past 3 years, the average E10 Growth Rate was 40.60% per year. During the past 5 years, the average E10 Growth Rate was 27.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Laboratorios Farmaceuticos Rovi was 40.60% per year. The lowest was 17.90% per year. And the median was 34.40% per year.

As of today (2024-06-04), Laboratorios Farmaceuticos Rovi's current stock price is €89.55. Laboratorios Farmaceuticos Rovi's E10 for the quarter that ended in Mar. 2024 was €1.53. Laboratorios Farmaceuticos Rovi's Shiller PE Ratio of today is 58.53.

During the past 13 years, the highest Shiller PE Ratio of Laboratorios Farmaceuticos Rovi was 105.81. The lowest was 30.06. And the median was 47.85.


Laboratorios Farmaceuticos Rovi E10 Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi E10 Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.54 0.82 1.19 1.50

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.31 1.41 1.50 1.53

Competitive Comparison of Laboratorios Farmaceuticos Rovi's E10

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Shiller PE Ratio falls into.



Laboratorios Farmaceuticos Rovi E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Laboratorios Farmaceuticos Rovi's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.292/122.7621*122.7621
=0.292

Current CPI (Mar. 2024) = 122.7621.

Laboratorios Farmaceuticos Rovi Quarterly Data

per share eps CPI Adj_EPS
201406 0.181 101.081 0.220
201409 0.098 100.441 0.120
201412 0.086 100.251 0.105
201503 0.130 99.474 0.160
201506 0.144 101.138 0.175
201509 0.060 99.559 0.074
201512 0.067 100.268 0.082
201603 0.191 98.638 0.238
201606 0.174 100.333 0.213
201609 0.071 99.737 0.087
201612 0.093 101.842 0.112
201703 0.129 100.896 0.157
201706 0.190 101.848 0.229
201709 0.026 101.524 0.031
201712 0.004 102.975 0.005
201803 0.139 102.122 0.167
201806 0.014 104.165 0.016
201809 0.164 103.818 0.194
201812 0.041 104.193 0.048
201903 0.125 103.488 0.148
201906 0.167 104.612 0.196
201909 0.262 103.905 0.310
201912 0.155 105.015 0.181
202003 0.251 103.469 0.298
202006 0.283 104.254 0.333
202009 0.311 103.521 0.369
202012 0.257 104.456 0.302
202103 0.430 104.857 0.503
202106 0.491 107.102 0.563
202109 0.865 107.669 0.986
202112 0.988 111.298 1.090
202203 0.984 115.153 1.049
202206 0.517 118.044 0.538
202209 0.797 117.221 0.835
202212 1.493 117.650 1.558
202303 0.906 118.948 0.935
202306 0.360 120.278 0.367
202309 0.984 121.343 0.996
202312 0.994 121.300 1.006
202403 0.292 122.762 0.292

Add all the adjusted EPS together and divide 10 will get our e10.


Laboratorios Farmaceuticos Rovi  (XMAD:ROVI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Laboratorios Farmaceuticos Rovi's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=89.55/1.53
=58.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Laboratorios Farmaceuticos Rovi was 105.81. The lowest was 30.06. And the median was 47.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Laboratorios Farmaceuticos Rovi E10 Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Headlines

From GuruFocus

ITC Reaffirms TiVo's Second Infringement Victory

By Business Wire Business Wire 04-23-2020

27% Upside potentially in Rovi Corporation

By Bavneet Singh Nagpal bavinagpal 03-17-2015

TiVo Corporation to Announce First Quarter 2020 Results

By Business Wire Business Wire 04-23-2020

Rovi Corp. (ROVI) EVP & CFO James Budge sells 10,833 Shares

By GuruFocus Research GuruFocus Editor 02-03-2011

George Soros Buys Rovi Corp

By Kyle Ferguson Kyle Ferguson 09-08-2016

Rovi Corp. (ROVI) EVP & CFO James Budge sells 29,583 Shares

By GuruFocus Research GuruFocus Editor 01-07-2011